10 insiders reported 35 Form 4 transactions for CONDUIT PHARMACEUTICALS INC. (CDT) over the past 18 months (most recent 2026-06-23). Recent activity: Prospect Capital Securities Ltd (10% Owner) Sell 1.5M shares, Prospect Capital Securities Ltd (10% Owner) Sell 5,000 shares, Prospect Finance Ltd (10% Owner) Sell 5,000 shares, Taylor Mark Andrew (10% Owner) Sell 1.5M shares, Taylor Mark Andrew (10% Owner) Sell 5,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-23 | Prospect Capital Securities Ltd | 10% Owner | Sell | 1.5M | $2.1M |
| 2026-06-23 | Prospect Capital Securities Ltd | 10% Owner | Sell | 5,000 | $3,526 |
| 2026-06-23 | Prospect Finance Ltd | 10% Owner | Sell | 5,000 | $3,526 |
| 2026-06-23 | Taylor Mark Andrew | 10% Owner | Sell | 1.5M | $2.1M |
| 2026-06-23 | Taylor Mark Andrew | 10% Owner | Sell | 5,000 | $3,526 |
| 2026-06-23 | Prospect Finance Ltd | 10% Owner | Sell | 1.5M | $2.1M |
| 2026-06-23 | Taylor Mark Andrew | 10% Owner | Sell | 5,000 | $3,755 |
| 2026-06-23 | Prospect Capital Securities Ltd | 10% Owner | Sell | 5,000 | $3,755 |
| 2026-06-23 | Prospect Finance Ltd | 10% Owner | Sell | 5,000 | $3,755 |
| 2026-06-23 | Taylor Mark Andrew | 10% Owner | Sell | 593,289 | $829,121 |
| 2026-06-23 | Prospect Capital Securities Ltd | 10% Owner | Sell | 593,289 | $829,121 |
| 2026-06-23 | Prospect Finance Ltd | 10% Owner | Sell | 593,289 | $829,121 |
| 2026-05-14 | Regan Andrew | Chief Executive Officer | Buy | 147,401 | $0 |
| 2026-05-14 | Regan Andrew | Chief Executive Officer | Buy | 100,000 | $190,000 |
| 2026-03-30 | Taylor Mark Andrew | Insider | Sell | 46,902 | $0 |
| 2026-03-30 | Prospect Capital Securities Ltd | Insider | Sell | 46,902 | $0 |
| 2026-03-30 | Prospect Finance Ltd | Insider | Sell | 46,902 | $0 |
| 2026-03-30 | Taylor Mark Andrew | Insider | Buy | 51.4M | $0 |
| 2026-03-30 | Prospect Capital Securities Ltd | Insider | Buy | 51.4M | $0 |
| 2026-03-30 | Prospect Finance Ltd | Insider | Buy | 51.4M | $0 |
| 2026-02-23 | Farley Chele Chiavacci | Director | Buy | 10,553 | $10,975 |
| 2025-12-22 | Corvus Capital Ltd. | Insider | Buy | 224,800 | $402,392 |
| 2025-12-22 | Regan Andrew | Chief Executive Officer | Buy | 224,800 | $402,392 |
| 2025-09-22 | Regan Andrew | Chief Executive Officer | Buy | 1.1M | $772,800 |
| 2025-09-19 | Bligh James | CFO | Buy | 480,000 | $0 |
Source: SEC Form 4 filings · as of 2026-06-23